15/10/02说明:此前论坛服务器频繁出错,现已更换服务器。今后论坛继续数据库备份,不备份上传附件。

肝胆相照论坛

 

 

肝胆相照论坛 论坛 学术讨论& HBV English 效应性CD8 + T细胞来源的白细胞介素-10增强急性肝脏免疫 ...
查看: 523|回复: 1
go

效应性CD8 + T细胞来源的白细胞介素-10增强急性肝脏免疫病理 [复制链接]

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30441 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

1
发表于 2017-8-18 13:23 |只看该作者 |倒序浏览 |打印
Effector CD8+ T cell-derived interleukin-10 enhances acute liver immunopathology
Jessica Fioravanti
, Pietro Di Lucia
, Diletta Magini
, Federica Moalli
, Carolina Boni
, Alexandre Pierre Benechet
, Valeria Fumagalli
, Donato Inverso
, Andrea Vecchi
, Amleto Fiocchi
, Stefan Wieland
, Robert Purcell
, Carlo Ferrari
, Francis V. Chisari
, Luca G. Guidotti'Correspondence information about the author Luca G. GuidottiEmail the author Luca G. Guidotti
, Matteo Iannacone'Correspondence information about the author Matteo IannaconeEmail the author Matteo Iannacone
PlumX Metrics
DOI: http://dx.doi.org/10.1016/j.jhep.2017.04.020 |
hideArticle Info
Publication History
Published online: May 05, 2017Accepted: April 25, 2017Received in revised form: March 27, 2017Received: September 13, 2016

Highlights

    •Effector CD8+ T cells produce IL-10 upon hepatocellular antigen encounter.
    •IL-10 enhances IL-2 responsiveness.
    •IL-10 inhibits antigen-induced effector CD8+ T cell apoptosis.
    •CD8+ T cell-derived IL-10 supports liver immunopathology.

Background & Aims

Besides secreting pro-inflammatory cytokines, chemokines and effector molecules, effector CD8+ T cells that arise upon acute infection with certain viruses have been shown to produce the regulatory cytokine interleukin (IL)-10 and, therefore, contain immunopathology. Whether the same occurs during acute hepatitis B virus (HBV) infection and role that IL-10 might play in liver disease is currently unknown.
Methods

Mouse models of acute HBV pathogenesis, as well as chimpanzees and patients acutely infected with HBV, were used to analyse the role of CD8+ T cell-derived IL-10 in liver immunopathology.
Results

Mouse HBV-specific effector CD8+ T cells produce significant amounts of IL-10 upon in vivo antigen encounter. This is corroborated by longitudinal data in a chimpanzee acutely infected with HBV, where serum IL-10 was readily detectable and correlated with intrahepatic CD8+ T cell infiltration and liver disease severity. Unexpectedly, mouse and human CD8+ T cell-derived IL-10 was found to act in an autocrine/paracrine fashion to enhance IL-2 responsiveness, thus preventing antigen-induced HBV-specific effector CD8+ T cell apoptosis. Accordingly, the use of mouse models of HBV pathogenesis revealed that the IL-10 produced by effector CD8+ T cells promoted their own intrahepatic survival and, thus supported, rather than suppressed liver immunopathology.
Conclusion

Effector CD8+ T cell-derived IL-10 enhances acute liver immunopathology. Altogether, these results extend our understanding of the cell- and tissue-specific role that IL-10 exerts in immune regulation.

Lay summary: Interleukin-10 is mostly regarded as an immunosuppressive cytokine. We show here that HBV-specific CD8+ T cells produce IL-10 upon antigen recognition and that this cytokine enhances CD8+ T cell survival. As such, IL-10 paradoxically promotes rather than suppresses liver disease.
Keywords:
CD8+ T cells, IL-10, Liver immunopathology, Hepatitis B virus

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30441 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

2
发表于 2017-8-18 13:24 |只看该作者
效应性CD8 + T细胞来源的白细胞介素-10增强急性肝脏免疫病理学
杰西卡·菲奥拉万蒂
,Pietro Di Lucia
,Diletta Magini
,Federica Moalli
,卡罗莱纳州博尼
,Alexandre Pierre Benechet
,Valeria Fumagalli
,多纳托Inverso
安德烈·维奇
Amleto Fiocchi
,Stefan Wieland
,Robert Purcell
,卡罗法拉利
弗朗西斯·齐萨里
,Luca G. Guidotti关于作者Luca G. Guidotti的函件信件作者Luca G. Guidotti
,Matteo Iannacone'关于作者的通讯信息Matteo IannaconeEmail作者Matteo Iannacone
PlumX指标
DOI:http://dx.doi.org/10.1016/j.jhep.2017.04.020 |
隐藏文章信息
出版历史
2017年5月5日受理:2017年4月25日收到修改后的形式:2017年3月27日接收:2016年9月13日

强调

•效应性CD8 + T细胞在肝细胞抗原相遇时产生IL-10。
•IL-10增强IL-2反应。
•IL-10抑制抗原诱导的效应CD8 + T细胞凋亡。
•CD8 + T细胞衍生的IL-10支持肝脏免疫病理学。

背景与目标

治疗分泌促炎细胞因子,趋化因子和效应分子,已经显示产生调节性细胞因子白细胞介素(IL)-10,因此含有免疫病理学的效应性CD8 + T细胞已被推荐为某些病毒的感染感染。目前尚不清楚急性乙型肝炎病毒(HBV)感染和IL-10可能在肝脏疾病中发挥的作用。
方法

急性HBV发病机制的小鼠模型,以及黑猩猩和HBV感染者均用于分析CD8 + T细胞来源的IL-10在肝脏免疫病理学中的作用。
结果

小鼠HBV特异性效应子CD8 + T细胞在体内抗原相遇时产生大量的IL-10。黑猩猩急性感染HBV的纵向数据得到证实,其中血清IL-10易于检测,并与肝内CD8 + T细胞浸润和肝脏疾病严重程度相关。意外的是,发现小鼠和人CD8 + T细胞来源的IL-10以自分泌/旁分泌方式起作用以增强IL-2反应性,从而预防抗原诱导的HBV特异性效应物CD8 + T细胞凋亡使用小鼠模型的HBV发病机制显示,由效应性CD8 + T细胞产生的IL-10促进了其自身的肝内存活,从而得到支持,而不是抑制肝脏免疫病理学。
结论

效应性CD8 + T细胞衍生的IL-10增强急性肝脏免疫病理学。总之,这些结果扩大了我们对IL-10在免疫调节中的细胞和组织特异性作用的理解。

进展情况:白细胞介素-10主要作为免疫抑制细胞因子有影响。我们在这里显示,HBV特异性CD8 + T细胞在抗原识别后产生IL-10,并且该细胞因子增强CD8 + T细胞的存活。因此,IL-10矛盾地抑制肝脏疾病。
关键词:
CD8 + T细胞,IL-10,肝脏免疫病理学,乙型肝炎病毒
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册

肝胆相照论坛

GMT+8, 2024-4-20 15:19 , Processed in 0.013511 second(s), 11 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.